ARGX

argenx SE NASDAQ

Healthcare ·Biotechnology ·NL · argenx.com

$811.09

Pre-mkt $812.16 +0.13%

Mkt Cap $50.2B

52w Low $510.06 70.9% of range 52w High $934.62

50d MA $759.02 200d MA $780.36

P/E (TTM) 37.1x

EV/EBITDA 49.5x

P/B 6.6x

Debt/Equity 0.0x

ROE —

P/FCF 61.1x

RSI (14) —

ATR (14) —

Beta -0.09

50d MA $759.02

200d MA $780.36

Avg Volume 340.6K

About

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Oct 30, 2025	AMC	4.37	5.18	+18.5%	820.36	+1.0%	-0.2%	+0.7%	+1.4%	+1.5%	+3.7%	+9.1%	—
May 8, 2025	AMC	0.98	2.58	+163.3%	569.12	+0.1%	-3.4%	-1.4%	-4.7%	-6.5%	-1.3%	+2.5%	—
Mar 31, 2025	AMC	—	2.58	—	591.87	+0.0%	-4.2%	-1.4%	-0.3%	-6.2%	-7.1%	+9.0%	—
Oct 31, 2024	AMC	0.10	1.39	+1290.0%	586.30	+0.9%	+1.6%	+0.4%	+2.8%	+0.5%	+0.9%	+5.3%	—
Sep 30, 2024	AMC	—	1.39	—	542.08	-0.3%	+1.0%	+1.5%	+0.2%	-2.2%	-3.6%	+1.8%	—
May 9, 2024	AMC	-0.71	-1.04	-46.5%	382.55	+0.1%	-2.1%	-6.0%	-6.9%	-1.5%	-1.6%	-0.8%	—
Mar 31, 2024	AMC	—	-1.04	—	—	—	—	—	—	—	—	—	—
Oct 31, 2023	AMC	-1.48	-1.25	+15.5%	469.57	+0.8%	+5.4%	+4.8%	+6.5%	+5.0%	+5.9%	-4.0%	—
Sep 30, 2023	AMC	—	-1.25	—	—	—	—	—	—	—	—	—	—
Jun 21, 2023	AMC	—	0.82	—	399.37	-0.8%	+0.3%	-0.7%	-2.9%	-4.9%	-3.7%	+37.3%	—
May 4, 2023	AMC	-2.34	-0.52	+77.8%	395.41	+1.1%	+2.2%	+2.7%	+1.5%	+1.8%	+2.9%	+1.8%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 2	Oppenheimer	Maintains	Outperform → Outperform	—	$743.12	$735.46	-1.0%	+0.4%	+0.7%	+3.0%	+5.6%	+7.7%
Mar 9	Wedbush	Maintains	Outperform → Outperform	—	$717.80	$715.73	-0.3%	+3.1%	+3.5%	+1.4%	-1.2%	-2.4%
Feb 27	Wells Fargo	Maintains	Overweight → Overweight	—	$771.53	$774.00	+0.3%	-0.6%	-1.9%	-3.0%	-2.8%	-5.6%
Feb 27	Citizens	Maintains	Market Outperform → Market Outperform	—	$771.53	$774.00	+0.3%	-0.6%	-1.9%	-3.0%	-2.8%	-5.6%
Feb 27	Guggenheim	Maintains	Buy → Buy	—	$771.53	$774.00	+0.3%	-0.6%	-1.9%	-3.0%	-2.8%	-5.6%
Feb 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$771.53	$774.00	+0.3%	-0.6%	-1.9%	-3.0%	-2.8%	-5.6%
Feb 27	Baird	Maintains	Neutral → Neutral	—	$771.53	$774.00	+0.3%	-0.6%	-1.9%	-3.0%	-2.8%	-5.6%
Feb 27	RBC Capital	Maintains	Outperform → Outperform	—	$771.53	$774.00	+0.3%	-0.6%	-1.9%	-3.0%	-2.8%	-5.6%
Jan 20	Wells Fargo	Maintains	Overweight → Overweight	—	$800.01	$785.53	-1.8%	+1.2%	+2.0%	+3.4%	+1.8%	+4.1%
Jan 14	Wedbush	Maintains	Outperform → Outperform	—	$810.51	$809.26	-0.2%	-1.4%	+0.3%	-1.3%	-0.1%	+0.7%
Jan 8	Truist	Maintains	Buy → Buy	—	$822.94	$826.67	+0.5%	-3.3%	-4.2%	-3.3%	-1.5%	-2.9%
Jan 8	Citigroup	Maintains	Buy → Buy	—	$822.94	$826.67	+0.5%	-3.3%	-4.2%	-3.3%	-1.5%	-2.9%
Dec 18	Baird	Downgrade	Outperform → Neutral	—	$862.05	$858.35	-0.4%	-1.7%	-0.8%	-1.2%	-1.9%	-1.4%
Dec 17	RBC Capital	Maintains	Outperform → Outperform	—	$851.42	$865.33	+1.6%	+1.2%	-0.5%	+0.4%	+0.1%	-0.6%
Dec 16	Wells Fargo	Maintains	Overweight → Overweight	—	$850.95	$853.99	+0.4%	+0.1%	+1.3%	-0.5%	+0.5%	+0.1%
Dec 11	Stifel	Maintains	Buy → Buy	—	$890.11	$887.14	-0.3%	-0.1%	-1.4%	-4.4%	-4.3%	-3.2%
Dec 11	Wells Fargo	Maintains	Overweight → Overweight	—	$890.11	$887.14	-0.3%	-0.1%	-1.4%	-4.4%	-4.3%	-3.2%
Dec 8	JP Morgan	Maintains	Overweight → Overweight	—	$901.17	$912.88	+1.3%	-0.0%	-1.3%	-1.2%	-1.3%	-2.6%
Dec 4	Morgan Stanley	Maintains	Overweight → Overweight	—	$921.80	$926.47	+0.5%	-0.6%	-2.2%	-2.3%	-3.5%	-3.4%
Nov 24	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$918.92	$914.62	-0.5%	-1.3%	-0.1%	-0.1%	-0.8%	-2.6%
Nov 17	Citigroup	Maintains	Buy → Buy	—	$907.98	$911.52	+0.4%	+2.4%	+1.2%	+0.7%	+1.2%	+1.2%
Nov 14	Wedbush	Maintains	Outperform → Outperform	—	$891.73	$881.25	-1.2%	+1.8%	+4.2%	+3.0%	+2.6%	+3.0%
Nov 7	JP Morgan	Maintains	Overweight → Overweight	—	$851.02	$856.48	+0.6%	+0.4%	+2.2%	+4.5%	+4.6%	+4.8%
Nov 4	Piper Sandler	Maintains	Overweight → Overweight	—	$826.28	$825.36	-0.1%	+0.6%	+0.7%	+3.0%	+3.4%	+5.3%
Oct 31	TD Cowen	Maintains	Buy → Buy	—	$820.36	$828.85	+1.0%	-0.2%	+0.7%	+1.4%	+1.5%	+3.7%
Oct 31	Evercore ISI	Maintains	Outperform → Outperform	—	$820.36	$828.85	+1.0%	-0.2%	+0.7%	+1.4%	+1.5%	+3.7%
Oct 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$820.36	$828.85	+1.0%	-0.2%	+0.7%	+1.4%	+1.5%	+3.7%
Oct 31	RBC Capital	Maintains	Outperform → Outperform	—	$820.36	$828.85	+1.0%	-0.2%	+0.7%	+1.4%	+1.5%	+3.7%
Oct 13	Wedbush	Maintains	Outperform → Outperform	—	$796.92	$796.73	-0.0%	+0.3%	+2.0%	+2.3%	+5.1%	+5.9%
Oct 1	Morgan Stanley	Maintains	Overweight → Overweight	—	$737.56	$775.92	+5.2%	+4.0%	+7.3%	+8.5%	+6.8%	+8.1%
Sep 18	Guggenheim	Maintains	Buy → Buy	—	$734.35	$731.47	-0.4%	-0.4%	+0.3%	+0.8%	+0.0%	-0.6%
Sep 15	Truist	Maintains	Buy → Buy	—	$756.38	$757.99	+0.2%	+0.1%	-0.5%	-2.9%	-3.3%	-2.6%
Sep 2	BofA Securities	Maintains	Buy → Buy	—	$712.20	$712.01	-0.0%	-0.8%	+1.4%	+3.0%	+5.4%	+7.8%
Aug 26	Piper Sandler	Maintains	Overweight → Overweight	—	$677.32	$698.26	+3.1%	+4.5%	+4.5%	+3.9%	+5.1%	+4.3%
Aug 4	JP Morgan	Maintains	Overweight → Overweight	—	$673.80	$679.77	+0.9%	+2.5%	+0.2%	-0.1%	-0.2%	-1.8%
Aug 1	Guggenheim	Maintains	Buy → Buy	—	$670.33	$672.58	+0.3%	+0.5%	+3.0%	+0.7%	+0.4%	+0.3%
Aug 1	Morgan Stanley	Maintains	Overweight → Overweight	—	$670.33	$672.58	+0.3%	+0.5%	+3.0%	+0.7%	+0.4%	+0.3%
Aug 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$670.33	$672.58	+0.3%	+0.5%	+3.0%	+0.7%	+0.4%	+0.3%
Jul 31	Wells Fargo	Maintains	Overweight → Overweight	—	$598.89	$688.38	+14.9%	+11.9%	+12.5%	+15.3%	+12.7%	+12.4%
Jul 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$551.22	$555.38	+0.8%	-1.6%	-1.1%	-1.4%	-0.9%	-2.3%
Jun 24	Wedbush	Maintains	Outperform → Outperform	—	$540.76	$549.58	+1.6%	+5.0%	+3.7%	+3.6%	+3.6%	+1.9%
Jun 11	HC Wainwright & Co.	Maintains	Buy → Buy	—	$575.46	$578.87	+0.6%	-0.1%	+2.0%	+0.4%	-4.2%	-6.0%
Jun 11	Wedbush	Maintains	Outperform → Outperform	—	$575.46	$578.87	+0.6%	-0.1%	+2.0%	+0.4%	-4.2%	-6.0%
Jun 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$583.62	$586.80	+0.5%	-1.4%	-1.5%	+0.5%	-1.0%	-5.6%
May 13	Baird	Upgrade	Neutral → Outperform	—	$560.90	$557.37	-0.6%	-3.3%	-5.1%	+0.2%	+0.8%	+3.1%
May 9	Oppenheimer	Maintains	Outperform → Outperform	—	$569.12	$569.60	+0.1%	-3.4%	-1.4%	-4.7%	-6.5%	-1.3%
May 9	Citigroup	Maintains	Buy → Buy	—	$569.12	$569.60	+0.1%	-3.4%	-1.4%	-4.7%	-6.5%	-1.3%
May 9	Guggenheim	Maintains	Buy → Buy	—	$569.12	$569.60	+0.1%	-3.4%	-1.4%	-4.7%	-6.5%	-1.3%
Apr 17	Citigroup	Maintains	Buy → Buy	—	$587.59	$590.90	+0.6%	+1.5%	+1.4%	+2.1%	+1.2%	+2.2%
Apr 16	Wedbush	Maintains	Outperform → Outperform	—	$605.38	$600.30	-0.8%	-2.9%	-1.5%	-1.6%	-0.9%	-1.8%

Data updated apr 26, 2026 9:37am · Source: massive.com